| Fri, 18 Jan 2019 15:42:03: | DTC tax deductions back on the chopping block—and this time, the ax might just fall
|
| Fri, 18 Jan 2019 15:11:19: | FDA panel split on Sanofi's Type 1 diabetes hopeful Zynquista
|
| Fri, 18 Jan 2019 14:44:43: | RK Pharma leases part of Pfizer’s Pearl River, New York campus for manufacturing
|
| Fri, 18 Jan 2019 14:39:54: | Sun Pharma drops to 6-year low on report of another whistleblower complaint
|
| Fri, 18 Jan 2019 14:34:48: | Troubled Immunomedics now hit with CRL for breast cancer drug candidate
|
| Fri, 18 Jan 2019 14:22:30: | No bidding war for Loxo, so did Lilly overpay? Don’t rush to judgment, analysts say
|
| Fri, 18 Jan 2019 14:04:43: | On heels of Loxo buy, Lartruvo setback deals a blow to Lilly's oncology hopes
|
| Fri, 18 Jan 2019 09:57:13: | FiercePharmaAsia—Gilead’s clinical VP; Aurobindo buys Spectrum assets; Aslan’s lead drug
|
| Thu, 17 Jan 2019 15:26:10: | Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
|
| Thu, 17 Jan 2019 15:11:05: | Israeli authorities to demand $271M bill from tax-advantaged Teva: report
|
| Wed, 16 Jan 2019 22:54:24: | Amgen's once-dismissed osteoporosis drug Evenity 'back in the game' after rosy FDA panel vote
|
| Wed, 16 Jan 2019 16:42:20: | Pfizer partners with Medochemie to make drugs in Vietnam
|
| Wed, 16 Jan 2019 16:40:46: | Reckitt CEO plots exit amid consumer health split, and investors aren't happy
|
| Wed, 16 Jan 2019 15:34:36: | Acadia looks to 'blow up the paradigm' with Parkinson's psychosis drug Nuplazid
|
| Wed, 16 Jan 2019 15:13:54: | FDA recalls inspectors as shutdown drags on; Gottlieb calls PDUFA most 'vulnerable'
|
| Wed, 16 Jan 2019 14:51:21: | Sackler family directed—and covered up—Purdue's opioid sales tactics. Now, it should pay the price: AG
|
| Wed, 16 Jan 2019 14:48:57: | Allergan and Mohawk tribe ask SCOTUS to review controversial Restasis patent licensing deal
|
| Wed, 16 Jan 2019 12:49:24: | Merck bumps Keytruda credibility with real doctor appearance in latest ‘Tru’ patient ads
|
| Tue, 15 Jan 2019 16:27:04: | No means no: Global pharma group bans any and all gifts to doctors
|
| Tue, 15 Jan 2019 16:24:34: | Acorda's sales team switches gears to push crucial Parkinson's launch Inbrija
|
| Tue, 15 Jan 2019 16:05:10: | Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there's no connection
|
| Tue, 15 Jan 2019 14:58:05: | Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices
|
| Tue, 15 Jan 2019 14:45:51: | Copay coupons help (a little) with CV drug adherence but not outcomes: study
|
| Tue, 15 Jan 2019 14:31:51: | AHA says penalties as well as incentives are needed to face down 'persistent' drug shortages
|
| Mon, 14 Jan 2019 21:59:06: | Merck's Keytruda slashes death risk by 31% in esophageal cancer victory
|
